_the-state-of-pharmaceuticals-bristol-myers-squibb39s-plan-to-buy-rayzebio-preview-1.jpg "The state of pharmaceuticals: Bristol-Myers Squibb's plan to buy RayzeBio from bms investor slides Video Screenshot Preview 1")
Gallery_the-state-of-pharmaceuticals-bristol-myers-squibb39s-plan-to-buy-rayzebio-preview-3.jpg "The state of pharmaceuticals: Bristol-Myers Squibb's plan to buy RayzeBio from bms investor slides Video Screenshot Preview 3")
Gallery_the-state-of-pharmaceuticals-bristol-myers-squibb39s-plan-to-buy-rayzebio-preview-hqdefault.jpg "The state of pharmaceuticals: Bristol-Myers Squibb's plan to buy RayzeBio from bms investor slides Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 46 seconds
👁 View: 2.1K times
Play Audio:👁 View: 2.1K times
Description:
CNBC Television
CNBC Television
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_3610-billion-in-free-cash-flow-8-yield-bristol-myers-squibb-company-36bmy-stock-to-own-in-2024.webp "Rational Investing with Cameron Stewart, CFA")
$10 Billion in Free Cash Flow, 8% Yield - Bristol-Myers Squibb Company ($BMY) - Stock to own in 2024
⏲ 20 minutes 25 seconds 👁 8K
_bristol-myers-squibb-to-buy-karuna-therapeutics-for-3614-billion-in-cash.webp "CNBC Television")
_bristol-myers-squibb-ceo-on-cancer-drug-pipeline.webp "CNBC Television")
_bristol-myers-stock-analysis-risks-amp-upside-potential124-bmy.webp "The Patient Investor")
_bristol-myers-ceo-says-the-company-is-in-transition.webp "Bloomberg Television")
_bristol-myers-squibb-ceo-we-are-on-track-to-continue-delivering-growth.webp "CNBC Television")
_bristol-myers-squibb-ceo-on-the-latest-advances-in-cancer-treatment.webp "CNBC Television")
_bic-viii-cstar-zash-enterprise.webp "JP PMS")
_3610-billion-in-free-cash-flow-8-yield-bristol-myers-squibb-company-36bmy-stock-to-own-in-2024.jpg)
_bristol-myers-squibb-to-buy-karuna-therapeutics-for-3614-billion-in-cash.jpg)
_bristol-myers-squibb-ceo-on-cancer-drug-pipeline.jpg)
_bristol-myers-stock-analysis-risks-amp-upside-potential124-bmy.jpg)
_bristol-myers-ceo-says-the-company-is-in-transition.jpg)
_bristol-myers-squibb-ceo-we-are-on-track-to-continue-delivering-growth.jpg)
_bristol-myers-squibb-ceo-on-the-latest-advances-in-cancer-treatment.jpg)
_bic-viii-cstar-zash-enterprise.jpg)
![[+]](/images/menu.gif){kind=small}